Literature DB >> 26648076

Design of Lipophilic Prodrugs to Improve Drug Delivery and Efficacy.

Abhirup Mandal, Mitesh Patel, Ye Sheng, Ashim K Mitra1.   

Abstract

Poor absorption, short half-life and resistance development are some of the major factors responsible for reduced drug efficacy. Lipophilic prodrugs can offer certain advantages to overcome these challenges. Chemical derivatization of hydrophilic agents with lipophilic pro-moieties can significantly elevate drug diffusion across absorptive membranes. Moreover, the desired linkage (ester vs. amide) may be selected to improve stability in vivo. Importantly, an appropriate selection of pro-moiety (targeting ligand) may promote drug specificity and selectivity. In this review article, an attempt has been made to summarize lipophilic prodrugs employed to improve delivery and efficacy of a wide range of poorly permeable but highly potent therapeutic agents. In addition, a brief overview on recent application of lipophilic prodrugs to promote encapsulation of hydrophilic agents in nano-sized drug carriers has been provided.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26648076     DOI: 10.2174/1389450117666151209115431

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  4 in total

1.  Delivery of a model lipophilic membrane cargo to bone marrow via cell-derived microparticles.

Authors:  Chunyan Yang; Fangfang Chen; Ping Ren; Laren Lofchy; Chun Wan; Jingshi Shen; Guankui Wang; Hanmant Gaikwad; Jessica Ponder; Craig T Jordan; Robert Scheinman; Dmitri Simberg
Journal:  J Control Release       Date:  2020-07-16       Impact factor: 9.776

Review 2.  Borneol: a Promising Monoterpenoid in Enhancing Drug Delivery Across Various Physiological Barriers.

Authors:  Madhur Kulkarni; Niserga Sawant; Anjali Kolapkar; Aishwarya Huprikar; Namita Desai
Journal:  AAPS PharmSciTech       Date:  2021-04-28       Impact factor: 3.246

3.  Circumvention of P-gp and MRP2 mediated efflux of lopinavir by a histidine based dipeptide prodrug.

Authors:  Abhirup Mandal; Dhananjay Pal; Ashim K Mitra
Journal:  Int J Pharm       Date:  2016-08-16       Impact factor: 5.875

4.  Enhanced Anti-Tumor Effect of Folate-Targeted FA-AMA-hyd-DOX Conjugate in a Xenograft Model of Human Breast Cancer.

Authors:  Tian-Tian Liao; Jiang-Fan Han; Fei-Yue Zhang; Ren Na; Wei-Liang Ye
Journal:  Molecules       Date:  2021-11-24       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.